Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Baxter
Boehringer Ingelheim
Merck

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Orion Pharma Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORION PHARMA, and what generic and branded alternatives to ORION PHARMA drugs are available?

ORION PHARMA has two approved drugs.



Summary for Orion Pharma
US Patents:0
Tradenames:7
Ingredients:2
NDAs:2

Drugs and US Patents for Orion Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma STALEVO 150 carbidopa; entacapone; levodopa TABLET;ORAL 021485-003 Jun 11, 2003 AB RX Yes No ⤷  Try it Free ⤷  Try it Free
Orion Pharma STALEVO 100 carbidopa; entacapone; levodopa TABLET;ORAL 021485-002 Jun 11, 2003 AB RX Yes No ⤷  Try it Free ⤷  Try it Free
Orion Pharma STALEVO 50 carbidopa; entacapone; levodopa TABLET;ORAL 021485-001 Jun 11, 2003 RX Yes Yes ⤷  Try it Free ⤷  Try it Free
Orion Pharma STALEVO 200 carbidopa; entacapone; levodopa TABLET;ORAL 021485-004 Aug 2, 2007 RX Yes Yes ⤷  Try it Free ⤷  Try it Free
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free
Orion Pharma STALEVO 125 carbidopa; entacapone; levodopa TABLET;ORAL 021485-006 Aug 29, 2008 RX Yes No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Orion Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma STALEVO 75 carbidopa; entacapone; levodopa TABLET;ORAL 021485-005 Aug 29, 2008 5,135,950 ⤷  Try it Free
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 6,599,530 ⤷  Try it Free
Orion Pharma STALEVO 100 carbidopa; entacapone; levodopa TABLET;ORAL 021485-002 Jun 11, 2003 6,797,732 ⤷  Try it Free
Orion Pharma STALEVO 150 carbidopa; entacapone; levodopa TABLET;ORAL 021485-003 Jun 11, 2003 5,135,950 ⤷  Try it Free
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 4,963,590 ⤷  Try it Free
Orion Pharma STALEVO 150 carbidopa; entacapone; levodopa TABLET;ORAL 021485-003 Jun 11, 2003 6,797,732 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ORION PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 25/100/200 mg and 37.5/150/200 mg ➤ Subscribe 2007-06-29
➤ Subscribe Tablets 25/100/200 mg and 37.5/150/200 mg ➤ Subscribe 2007-06-29
➤ Subscribe Tablets 12.5 mg, 50 mg and 200 mg ➤ Subscribe 2008-08-05
➤ Subscribe Tablets 200 mg ➤ Subscribe 2007-04-11
➤ Subscribe Tablets 18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg ➤ Subscribe 2009-05-19
➤ Subscribe Tablets 50 mg/200 mg/200 mg ➤ Subscribe 2008-08-28
➤ Subscribe Tablets 18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg ➤ Subscribe 2009-05-19
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Baxter
Harvard Business School
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.